Skip to main content
Journal cover image

RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.

Publication ,  Journal Article
Chai, X; Domchek, S; Kauff, N; Rebbeck, T; Chen, J
Published in: Journal of the National Cancer Institute
September 2015

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Journal of the National Cancer Institute

DOI

EISSN

1460-2105

ISSN

0027-8874

Publication Date

September 2015

Volume

107

Issue

9

Start / End Page

djv217

Related Subject Headings

  • Salpingectomy
  • Risk Reduction Behavior
  • Ovariectomy
  • Oncology & Carcinogenesis
  • Humans
  • Heterozygote
  • Female
  • Breast Neoplasms
  • BRCA2 Protein
  • BRCA1 Protein
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chai, X., Domchek, S., Kauff, N., Rebbeck, T., & Chen, J. (2015). RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction. Journal of the National Cancer Institute, 107(9), djv217. https://doi.org/10.1093/jnci/djv217
Chai, Xinglei, Susan Domchek, Noah Kauff, Timothy Rebbeck, and Jinbo Chen. “RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.Journal of the National Cancer Institute 107, no. 9 (September 2015): djv217. https://doi.org/10.1093/jnci/djv217.
Chai X, Domchek S, Kauff N, Rebbeck T, Chen J. RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction. Journal of the National Cancer Institute. 2015 Sep;107(9):djv217.
Chai, Xinglei, et al. “RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction.Journal of the National Cancer Institute, vol. 107, no. 9, Sept. 2015, p. djv217. Epmc, doi:10.1093/jnci/djv217.
Chai X, Domchek S, Kauff N, Rebbeck T, Chen J. RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction. Journal of the National Cancer Institute. 2015 Sep;107(9):djv217.
Journal cover image

Published In

Journal of the National Cancer Institute

DOI

EISSN

1460-2105

ISSN

0027-8874

Publication Date

September 2015

Volume

107

Issue

9

Start / End Page

djv217

Related Subject Headings

  • Salpingectomy
  • Risk Reduction Behavior
  • Ovariectomy
  • Oncology & Carcinogenesis
  • Humans
  • Heterozygote
  • Female
  • Breast Neoplasms
  • BRCA2 Protein
  • BRCA1 Protein